Position in LH
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$439,702
-$341 QoQ
Shares Held
1,648
-6.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Fisher Asset Management, LLC holds $2,371,928,626 across 9 Diagnostics & Research names. LH ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,851,579 | $1,401,636,625 | |
| 2 | DHR |
Danaher Corp /De/
|
4,606,434 | $873,379,886 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
135,712 | $65,167,545 | |
| 4 | VCYT |
Veracyte, Inc.
|
736,270 | $23,715,256 | |
| 5 | MYGN |
Myriad Genetics Inc
|
1,190,896 | $5,359,032 | |
| 6 | RVTY |
Revvity, Inc.
|
12,386 | $1,085,137 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
4,743 | $808,871 | |
| 8 | LH |
Labcorp Holdings Inc.
This page
|
1,648 | $439,702 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $439,702 | 1,648 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $440,043 | 1,754 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $496,613 | 1,730 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $435,766 | 1,660 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $425,448 | 1,828 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $466,207 | 2,033 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $279,126 | 1,249 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $253,776 | 1,247 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||